Exciting breakthroughs in Alzheimer’s disease research have led to the development of a new drugs called donanemab…which has shown promising results in slowing the progression of the disease by up to 35% in early-stage patients.
The medical community is enthusiastic about these developments, and the findings offer hope for patients and families affected by the devastating condition.
Produced By: Moemina Shukur
Featured In Story: Professor Blossom Stephan – Chair of Dementia Curtin University and Dementia Australia
First aired on The Wire, Tuesday 18 July 2023